Pfizer and GSK Compete For RSV Vaccine Market
Despite these historic approvals, GSK's supremacy in the unexplored RSV vaccine area is threatened by Pfizer, which is aggressively pursuing market share for its own RSV vaccine Abrysvo…
Quick News Bit